Sensus Healthcare, Inc.

NASDAQ:SRTS

Medical - Devices

Healthcare
$3.22 +3.05%

+$0.09 today

Market cap
$53.01M
Beta
1.09
P/E (TTM)
-6.5
EPS (TTM)
-$0.47
52W Low $2.66High $5.92

Volume 0.08M

Average 0.06M

SRTS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Sensus Healthcare, Inc.NASDAQ: SRTS

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 29.2%

Gross margin was 29.2% in Q1 FY2026, down 23.0 pp from a year earlier. On a trailing-twelve-month basis it was 37.7%, down 18.3 pp year over year. Over 3 fiscal years it narrowed by 23.4 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
29.2%-9.2 pp QoQ
Last fiscal yearDec 2025
43.2%-15.3 pp YoY
LTMMar 2026
37.7%-18.3 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-23.0 pp——
1 year-15.3 pp——
3 years-23.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
43.2%
Year-over-year change
-15.3pp

Gross Margin vs competitors

How SRTS compares with its peers on the latest reported figures

  • SRTS's LTM Mar 2026 gross margin of 37.7% is the lowest of the 6 companies compared; the peer median is 83.8%.
  • Its year-over-year change of -18.3 pp is the lowest of 6, against a peer median of -0.3 pp.
  • Over three fiscal years its change of -23.4 pp compares with a peer median of +2.4 pp.
SRTS Competitors Peer median
Gross Margin for SRTS and competitors
Company Period LTM level YoY 3-year change
KPTIKaryopharm Therapeutics Inc.LTM Mar 202696.0% -0.1 pp-0.8 pp
IPSCCentury Therapeutics, Inc.FY202588.0% -12.0 pp-12.0 pp
BDMDBaird Medical Investment Holdings LimitedFY202583.8% -4.4 pp+3.9 pp
TELATELA Bio, Inc.LTM Jun 202667.8% +0.5 pp+2.4 pp
MDAISpectral AI, Inc.LTM Mar 202644.7% -0.3 pp+2.7 pp
SRTSSensus Healthcare, Inc.LTM Mar 202637.7% -18.3 pp-23.4 pp
Peer median (excluding SRTS) 83.8%-0.3 pp+2.4 pp

Competitors are the stored peer set for SRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue27.04M44.53M24.41M41.81M27.48M
Cost of Revenue10.05M14.9M10.35M17.38M15.62M
Gross Profit16.99M29.63M14.06M24.43M11.87M
Gross Margin62.8%66.5%57.6%58.4%43.2%
Research & Development3.44M3.46M3.68M4.22M7.78M
Selling, General & Admin9.43M11.34M10.76M12.13M14.4M
Operating Expenses12.87M14.8M14.44M16.34M22.17M
Depreciation & Amortization613K509K461K432K386K
EBITDA4.73M28.5M1.11M9.45M(9.24M)
EBITDA Margin17.5%64.0%4.6%22.6%-33.6%
Operating Income4.12M14.83M(382K)8.09M(10.31M)
Operating Margin15.2%33.3%-1.6%19.4%-37.5%
Interest Income2K382K992K932K683K
Interest Expense1K2K000
Other Income / Expenses(1K)13.16M1.03M932K683K
Income Before Tax4.12M27.99M652K9.02M(9.62M)
Pre-Tax Margin15.2%62.9%2.7%21.6%-35.0%
Income Tax Expense03.75M167K2.38M(1.91M)
Net Income4.12M24.24M485K6.65M(7.72M)
Net Margin15.2%54.4%2.0%15.9%-28.1%
EPS (Basic)0.251.470.030.41(0.47)
EPS (Diluted)0.251.460.030.41(0.47)
Weighted Avg Shares16.48M16.48M16.26M16.31M16.33M
Weighted Avg Shares (Diluted)16.5M16.62M16.27M16.36M16.33M

Sensus Healthcare, Inc.

NASDAQ:SRTS

Intrinsic Alpha fair value

Locked

Current Price

$3.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.